266 related articles for article (PubMed ID: 1836754)
1. Effect of long-acting progestagen-only injectable contraceptives on carbohydrate metabolism and its hormonal profile.
Fahmy K; Abdel-Razik M; Shaaraway M; al-Kholy G; Saad S; Wagdi A; al-Azzony M
Contraception; 1991 Oct; 44(4):419-30. PubMed ID: 1836754
[TBL] [Abstract][Full Text] [Related]
2. Long-acting hormonal contraceptives for women.
Garza-Flores J; Hall PE; Perez-Palacios G
J Steroid Biochem Mol Biol; 1991; 40(4-6):697-704. PubMed ID: 1958567
[TBL] [Abstract][Full Text] [Related]
3. Acceptability of injectable contraceptives in Assiut, Egypt.
Salem HT; Salah M; Aly MY; Thabet AI; Shaaban MM; Fathalla MF
Contraception; 1988 Dec; 38(6):697-710. PubMed ID: 2975583
[TBL] [Abstract][Full Text] [Related]
4. WHO special programme of research, development and research training in human reproduction. Task force on long-acting agents for the regulation of fertility.
Contraception; 1982 Jan; 25(1):1-11. PubMed ID: 6460593
[TBL] [Abstract][Full Text] [Related]
5. A study of adrenal corticol function and its reserve activity in long-acting injectable contraceptive users.
Amatayakul K; Petpoo W; Ratanawananukul N; Tanthayaphinant O; Tovanabutra S; Suriyanon V
Contraception; 1988 May; 37(5):483-92. PubMed ID: 2970367
[TBL] [Abstract][Full Text] [Related]
6. The effects of long-acting injectable contraceptives on carbohydrate metabolism.
Amatayakul K; Suriyanon V
Int J Gynaecol Obstet; 1985 Oct; 23(5):361-8. PubMed ID: 2866986
[TBL] [Abstract][Full Text] [Related]
7. A prospective, one-year study on the effects of two long acting injectable contraceptives (depot-medroxyprogesterone acetate and norethisterone oenanthate) on serum and lipoprotein lipids.
Enk L; Landgren BM; Lindberg UB; Silfverstolpe G; Crona N
Horm Metab Res; 1992 Feb; 24(2):85-9. PubMed ID: 1533383
[TBL] [Abstract][Full Text] [Related]
8. A randomized, single blind comparative trial of norethindrone enanthate and depo-medroxyprogesterone acetate in Bangladesh.
Swenson I; Khan AR; Jahan FA
Contraception; 1980 Mar; 21(3):207-15. PubMed ID: 6446442
[TBL] [Abstract][Full Text] [Related]
9. Pituitary response to LHRH in long-term users of injectable contraceptives.
Ismail AA; el-Faras A; Rocca M; el-Sibai FA; Toppozada M
Contraception; 1987 May; 35(5):487-95. PubMed ID: 2957167
[TBL] [Abstract][Full Text] [Related]
10. Multinational comparative clinical trial of long-acting injectable contraceptives: norethisterone enanthate given in two dosage regimens and depot-medroxyprogesterone acetate. Final report.
Contraception; 1983 Jul; 28(1):1-20. PubMed ID: 6226488
[TBL] [Abstract][Full Text] [Related]
11. Effects of medroxyprogesterone acetate on serum lipids, protein, glucose tolerance and liver function in Thai women.
Amatayakul K; Sivassomboon B; Singkamani R
Contraception; 1980 Mar; 21(3):283-97. PubMed ID: 6446443
[TBL] [Abstract][Full Text] [Related]
12. Return to ovulation following the use of long-acting injectable contraceptives: a comparative study.
Garza-Flores J; Cardenas S; RodrÃguez V; Cravioto MC; Diaz-Sanchez V; Perez-Palacios G
Contraception; 1985 Apr; 31(4):361-6. PubMed ID: 3159544
[TBL] [Abstract][Full Text] [Related]
13. Serium protein-bound carbohydrate and seromucoid levels during long-acting progestational contraceptive therapy.
Saleh FM
Contraception; 1977 Oct; 16(4):399-407. PubMed ID: 923250
[TBL] [Abstract][Full Text] [Related]
14. Clinical evaluation of two monthly injectable contraceptives and their effects on some metabolic parameters.
Haiba NA; el-Habashy MA; Said SA; Darwish EA; Abdel-Sayed WS; Nayel SE
Contraception; 1989 Jun; 39(6):619-32. PubMed ID: 2666019
[TBL] [Abstract][Full Text] [Related]
15. Some metabolic and hormonal changes in women using long acting injectable contraceptives.
Abdel-sayed WS; Toppozada HK; Said SA; El-sayed OK
Alex J Pharm Sci; 1989 Mar; 3(1):29-32. PubMed ID: 12316139
[TBL] [Abstract][Full Text] [Related]
16. Long-term use of depot-norethisterone enanthate: effect on blood coagulation factors and menstrual bleeding patterns.
McEwan JA; Griffin M
Contraception; 1991 Dec; 44(6):639-48. PubMed ID: 1773620
[TBL] [Abstract][Full Text] [Related]
17. Insulin sensitivity is decreased in normal women by doses of ethinyl estradiol used in oral contraceptives.
Kojima T; Lindheim SR; Duffy DM; Vijod MA; Stanczyk FZ; Lobo RA
Am J Obstet Gynecol; 1993 Dec; 169(6):1540-4. PubMed ID: 8267059
[TBL] [Abstract][Full Text] [Related]
18. A comparative study of the metabolic effects of injectable and oral contraceptives.
Liew DF; Ng CS; Heng SH; Ratnam SS
Contraception; 1986 Apr; 33(4):385-94. PubMed ID: 2942334
[TBL] [Abstract][Full Text] [Related]
19. Carbohydrate metabolism in Gynanovlar 21 and Lyndiol 2.5 users.
Kamal I; Zaki K; Rashad S
Egypt Popul Fam Plann Rev; 1972 Jun; 5(1):67-77. PubMed ID: 12256028
[TBL] [Abstract][Full Text] [Related]
20. Carbohydrate metabolism of Indian women taking steroid contraceptives.
Barsivala VM; Virkar K; Kulkarni RD
Fertil Steril; 1976 Jan; 27(1):87-91. PubMed ID: 1245247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
